fashion -WSS

fashion

author：knowledge 2025-09-06 03:58:27 - browse：77

Mel Evans/AP

Merck announced Monday it will acquire Harpoon Therapeutics and its pipeline of immune-based cancer drugs for $680 million. Merck will pay $23 per share, just over twice Harpoon’s market price entering the week.

The bolt-on deal comes as Merck’s top brass searches for ways to bolster the company’s revenue after it loses exclusivity on Keytruda, long the world’s most lucrative cancer drug. That could come as soon as 2028.

Keytruda, a PD-(L)1 inhibitor, works by turning off a “brake” on T cells, allowing roving immune cells to attack tumors. Harpoon’s pipeline belongs to a new class of cancer drugs designed to grab onto the T cells and tumor cells and bring them together.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Lawsuit highlights wrinkle for disputes over surprise medical bills

knowledge

WSS

Medicare Advantage 2025 payments will dip, Biden administration says

RSV injection headlines need to be accurate for good uptake

Republican states more likely to report Covid vaccine side effects

Setback for rare diseases as Taysha Gene Therapies pulls back

Four alarming medical procedures we’re glad history forgot

Congress extends some pandemic preparedness programs

hotspot

fashion

focus

Duchenne breakthrough therapy leaves behind pioneering families

Bird flu reported in person exposed to presumably infected cattle

Drug repurposing or repositioning? The language matters

Pancreatic cancer is often deadly, but new discoveries are raising hope

Guidelines to prevent youth baseball injuries need more muscle

Some top drug companies are starting to take action on climate

In age of alternative facts, a scholarly course on calling out crap

People with mental disorders often marry others with same

Moonlake's readout produced a cash windfall. Risks remain

Harvard scientists, with Google, unveil the most detailed brain map ever

knowledge

Covid silver lining: Unprecedented look at human immune system

Scientists uncover potential path to treating deadly childhood tumor

Oral obesity drug from Viking Therapeutics hits key early target

WHO recommends second malaria vaccine

Covid silver lining: Unprecedented look at human immune system

People with mental disorders often marry others with same

explore

knowledge

explore

focus